Recherche
-
Myocardial infarction associated with erenumab: a case report.
(PHARMACOTHERAPY, 2022-05-27)Article de revueLibre accès -
Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control study
(BMJ. vol. 376, 2022-03-23)Article de revueLibre accès -
Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database
(Frontiers in Pharmacology. vol. 11, pp. 624562, 2021-03-24)Article de revueLibre accès -
Emergency room admissions induced by drug-drug interactions in the elderly: a cross-sectional study
(Clinical and Translational Science, 2022-03-04)Article de revueLibre accès -
Leveraging the Variability of Pharmacovigilance Disproportionality Analyses to Improve Signal Detection Performances
(Frontiers in Pharmacology. vol. 12, pp. 668765, 2021-05-28)Article de revueLibre accès -
Systematising Pharmacovigilance Engagement of Patients, Healthcare Professionals and Regulators: A Practical Decision Guide Derived from the International Risk Governance Framework for Engagement Events and Discourse
(Drug Safety. pp. 1193-1208, 2021-09-15)Article de revueLibre accès -
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study
(Drug Safety. vol. 46, n° 9, pp. 857-866, 2023-09-01)Article de revueLibre accès -
Use of sodium-glucose cotransporter-2 inhibitors in France: Analysis of French nationwide health insurance database
(Diabetes, Obesity and Metabolism, 2024-01-30)Article de revueLibre accès -
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
(Drug Safety. vol. 45, n° 5, pp. 535-548, 2022-05)Article de revueLibre accès -
Artificial intelligence for unstructured healthcare data: application to coding of patient reporting of adverse drug reactions
(Clinical Pharmacology and Therapeutics, 2021-04-18)Article de revueLibre accès